@phdthesis{Thakar2006,
  author    = {Thakar, Juilee},
  title     = {Computational models for the study of responses to infections},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-17266},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2006},
  abstract  = {In diesem Jahrhundert haben neue experimentelle Techniken und Computer-Verfahren enorme Mengen an Information erzeugt, die bereits viele biologische R{\"a}tsel enth{\"u}llt haben. Doch die Komplexit{\"a}t biologischer Systeme wirft immer weitere neue Fragen auf. Um ein System zu verstehen, bestand der Hauptansatz bis jetzt darin, es in Komponenten zu zerlegen, die untersucht werden k{\"o}nnen. Ein neues Paradigma verkn{\"u}pft die einzelnen Informationsteile, um sie auf globaler Ebene verstehen zu k{\"o}nnen. In der vorgelegten Doktorarbeit habe ich deshalb versucht, infekti{\"o}se Krankheiten mit globalen Methoden („Systembiologie") bioinformatisch zu untersuchen. Im ersten Teil wird der Apoptose-Signalweg analysiert. Apoptose (Programmierter Zelltod) wird bei verschiedenen Infektionen, zum Beispiel bei Viruserkrankungen, als Abwehrmaßnahme eingesetzt. Die Interaktionen zwischen Proteinen, die ‚death' Dom{\"a}nen beinhalten, wurden untersucht, um folgende Fragen zu kl{\"a}ren: i) wie wird die Spezifit{\"a}t der Interaktionen erzielt? -sie wird durch Adapter erreicht, ii) wie werden Proliferation/ {\"U}berlebenssignale w{\"a}hrend der Aktivierung der Apoptose eingeleitet? - wir fanden Hinweise f{\"u}r eine entscheidende Rolle des RIP Proteins (Rezeptor-Interagierende Serine/Threonine-Proteinkinase 1). Das Modell erlaubte uns, die Interaktions-Oberfl{\"a}chen von RIP vorherzusagen. Der Signalweg wurde anschließend auf globaler Ebene mit Simulationen f{\"u}r verschiedene Zeitpunkte analysiert, um die Evolution der Aktivatoren und Inhibitoren des Signalwegs und seine Struktur besser zu verstehen. Weiterhin wird die Signalverarbeitung f{\"u}r Apoptosis-Signalwege in der Maus detailliert modelliert, um den Konzentrationsverlauf der Effektor-Kaspasen vorherzusagen. Weitere experimentelle Messungen von Kaspase-3 und die {\"U}berlebenskurven von Zellen best{\"a}tigen das Modell. Der zweite Teil der Resultate konzentriert sich auf das Phagosom, eine Organelle, die eine entscheidende Rolle bei der Eliminierung von Krankheitserregern spielt. Dies wird am Beispiel von M. tuberculosis veranschaulicht. Die Fragestellung wird wiederum in zwei Aspekten behandelt: i) Um die Prozesse, die durch M. tuberculosis inhibiert werden zu verstehen, haben wir uns auf das Phospholipid-Netzwerk konzentriert, das bei der Unterdr{\"u}ckung oder Aktivierung der Aktin-Polymerisation eine große Rolle spielt. Wir haben f{\"u}r diese Netzwerkanalyse eine Simulation f{\"u}r verschiedene Zeitpunkte {\"a}hnlich wie in Teil eins angewandt. ii) Es wird vermutet, dass Aktin-Polymere bei der Fusion des Phagosoms mit dem Lysosom eine Rolle spielen. Um diese Hypothese zu untersuchen, wurde ein in silico Modell von uns entwickelt. Wir fanden heraus, dass in der Anwesenheit von Aktin-Polymeren die Suchzeit f{\"u}r das Lysosom um das F{\"u}nffache reduziert wurde. Weiterhin wurden die Effekte der L{\"a}nge der Aktin-Polymere, die Gr{\"o}ße der Lysosomen sowie der Phagosomen und etliche andere Modellparameter analysiert. Nach der Untersuchung eines Signalwegs und einer Organelle f{\"u}hrte der n{\"a}chste Schritt zur Untersuchung eines komplexen biologischen Systems der Infektabwehr. Dies wurde am Beispiel der Wirt-Pathogen Interaktion bei Bordetella pertussis und Bordetella bronchiseptica dargestellt. Die geringe Menge verf{\"u}gbarer quantitativer Daten war der ausschlaggebende Faktor bei unserer Modellwahl. F{\"u}r die dynamische Simulation wurde ein selbst entwickeltes Bool'sches Modell verwendet. Die Ergebnisse sagen wichtige Faktoren bei der Pathologie von Bordetellen hervor, besonders die Bedeutung der Th1 assoziierten Antworten und dagegen nicht der Th2 assoziierten Antworten f{\"u}r die Eliminierung des Pathogens. Einige der quantitativen Vorhersagen wurden durch Experimente wie die Untersuchung des Verlaufs einer Infektion in verschiedenen Mutanten und Wildtyp-M{\"a}usen {\"u}berpr{\"u}ft. Die begrenzte Verf{\"u}gbarkeit kinetischer Daten war der kritische Faktor bei der Auswahl der computer-gest{\"u}tzten Modelle. Der Erfolg unserer Modelle konnte durch den Vergleich mit experimentellen Beobachtungen belegt werden. Die vergleichenden Modelle in Kapitel 6 und 9 k{\"o}nnen zur Untersuchung neuer Wirt-Pathogen Interaktionen verwendet werden. Beispielsweise f{\"u}hrt in Kapitel 6 die Analyse von Inhibitoren und inhibitorischer Signalwege aus drei Organismen zur Identifikation wichtiger regulatorischer Zentren in komplexen Organismen und in Kapitel 9 erm{\"o}glicht die Identifikation von drei Phasen in B. bronchiseptica und der Inhibition von IFN-\&\#947; durch den Faktor TTSS die Untersuchung {\"a}hnlicher Phasen und die Inhibition von IFN-\&\#947; in B. pertussis. Eine weitere wichtige Bedeutung bekommen diese Modelle durch die m{\"o}gliche Identifikation neuer, essentieller Komponenten in Wirt-Pathogen Interaktionen. In silico Modelle der Effekte von Deletionen zeigen solche Komponenten auf, die anschließend durch experimentelle Mutationen weiter untersucht werden k{\"o}nnen.},
  subject      = {Bordetella pertussis},
  language  = {en}
}
@phdthesis{Narkhede2018,
  author    = {Narkhede, Yogesh},
  title     = {In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-152468},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2018},
  abstract  = {The high infection rates and recent emergence of extremely drug resistant forms of Mycobacterium tuberculosis pose a significant challenge for global health. The NADH- dependent enoyl-ACP-reductase InhA of the type II mycobacterial fatty acid biosynthesis pathway is a well-validated target for inhibiting mycobacterial growth. InhA has been shown to be inhibited by a variety of compound series. Prominent classes of InhA inhibitors from literature include diaryl ethers, pyrrolidine carboxamides and arylamides which can be subjected to further development. Despite the progress in this area, very few compounds are in clinical development phase. The present work involves a detailed computational investigation of the binding modes and structure-based optimisation of pyrrolidine carboxamides as InhA inhibitors. With substituents of widely varying bulkiness, the pyrrolidine carboxamide dataset presented a challenge for prediction of binding mode as well as affinity. Using advanced docking protocols and in-house developed pose selection procedures, the binding modes of 44 compounds were predicted. The poses from docking were used in short molecular dynamics (MD) simulations to ascertain the dominant binding conformations for the bulkier members of the series. Subsequently, an activity-based classification strategy could be developed to circumvent the affinity prediction problems observed with this dataset. The prominent motions of the bound ligand and the active site residues were then ascertained using Essential Dynamics (ED). The information from ED and literature was subsequently used to design a total of 20 compounds that were subjected to extensive in-silico evaluations. Finally, the molecular determinants of rapid-reversible binding of pyrrolidine carboxamides were investigated using long MD simulations.},
  subject      = {Tuberkelbakterium},
  language  = {en}
}
@phdthesis{Merget2015,
  author    = {Merget, Benjamin},
  title     = {Computational methods for assessing drug-target residence times in bacterial enoyl-ACP reductases and predicting small-molecule permeability for the \(Mycobacterium\) \(tuberculosis\) cell wall},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-127386},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2015},
  abstract  = {\textbf{Molecular Determinants of Drug-Target Residence Times of Bacterial Enoyl-ACP Reductases.} Whereas optimization processes of early drug discovery campaigns are often affinity-driven, the drug-target residence time \$t_R\$ should also be considered due to an often strong correlation with \textit{in vivo} efficacy of compounds. However, rational optimization of \$t_R\$ is not straightforward and generally hampered by the lack of structural information about the transition states of ligand association and dissociation. The enoyl-ACP reductase FabI of the fatty acid synthesis (FAS) type II is an important drug-target in antibiotic research. InhA is the FabI enzyme of \textit{Mycobacterium tuberculosis}, which is known to be inhibited by various compound classes. Slow-onset inhibition of InhA is assumed to be associated with the ordering of the most flexible protein region, the substrate binding loop (SBL). Diphenylethers are one class of InhA inhibitors that can promote such SBL ordering, resulting in long drug-target residence times. Although these inhibitors are energetically and kinetically well characterized, it is still unclear how the structural features of a ligand affect \$t_R\$. Using classical molecular dynamics (MD) simulations, recurring conformational families of InhA protein-ligand complexes were detected and structural determinants of drug-target residence time of diphenyl\-ethers with different kinetic profiles were described. This information was used to deduce guidelines for efficacy improvement of InhA inhibitors, including 5'-substitution on the diphenylether B-ring. The validity of this suggestion was then analyzed by means of MD simulations. Moreover, Steered MD (SMD) simulations were employed to analyze ligand dissociation of diphenylethers from the FabI enzyme of \textit{Staphylococcus aureus}. This approach resulted in a very accurate and quantitative linear regression model of the experimental \$ln(t_R)\$ of these inhibitors as a function of the calculated maximum free energy change of induced ligand extraction. This model can be used to predict the residence times of new potential inhibitors from crystal structures or valid docking poses. Since correct structural characterization of the intermediate enzyme-inhibitor state (EI) and the final state (EI*) of two-step slow-onset inhibition is crucial for rational residence time optimization, the current view of the EI and EI* states of InhA was revisited by means of crystal structure analysis, MD and SMD simulations. Overall, the analyses affirmed that the EI* state is a conformation resembling the 2X23 crystal structure (with slow-onset inhibitor \textbf{PT70}), whereas a twist of residues Ile202 and Val203 with a further opened helix \$\alpha 6\$ corresponds to the EI state. Furthermore, MD simulations emphasized the influence of close contacts to symmetry mates in the SBL region on SBL stability, underlined by the observation that an MD simulation of \textbf{PT155} chain A with chain B' of a symmetry mate in close proximity of the SBL region showed significantly more stable loops, than a simulation of the tetrameric assembly. Closing Part I, SMD simulations were employed which allow the delimitation of slow-onset InhA inhibitors from rapid reversible ligands. \textbf{Prediction of \textit{Mycobacterium tuberculosis} Cell Wall Permeability.} The cell wall of \textit{M. tuberculosis} hampers antimycobacterial drug design due to its unique composition, providing intrinsic antibiotic resistance against lipophilic and hydrophilic compounds. To assess the druggability space of this pathogen, a large-scale data mining endeavor was conducted, based on multivariate statistical analysis of differences in the physico-chemical composition of a normally distributed drug-like chemical space and a database of antimycobacterial--and thus very likely permeable--compounds. The approach resulted in the logistic regression model MycPermCheck, which is able to predict the permeability probability of small organic molecules based on their physico-chemical properties. Evaluation of MycPermCheck suggests a high predictive power. The model was implemented as a freely accessible online service and as a local stand-alone command-line version. Methodologies and findings from both parts of this thesis were combined to conduct a virtual screening for antimycobacterial substances. MycPermCheck was employed to screen the chemical permeability space of \textit{M. tuberculosis} from the entire ZINC12 drug-like database. After subsequent filtering steps regarding ADMET properties, InhA was chosen as an exemplary target. Docking to InhA led to a principal hit compound, which was further optimized. The quality of the interaction of selected derivatives with InhA was subsequently evaluated using MD and SMD simulations in terms of protein and ligand stability, as well as maximum free energy change of induced ligand egress. The results of the presented computational experiments suggest that compounds with an indole-3-acethydrazide scaffold might constitute a novel class of InhA inhibitors, worthwhile of further investigation.},
  subject      = {Computational chemistry},
  language  = {en}
}
@phdthesis{Luckner2009,
  author    = {Luckner, Sylvia},
  title     = {Towards the development of high affinity InhA and KasA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-43621},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2009},
  abstract  = {Mycobacterium tuberculosis is the causative agent of tuberculosis and responsible for more than eight million new infections and about two million deaths each year. Novel chemotherapeutics are urgently needed to treat the emerging threat of multi drug resistant and extensively drug resistant strains. Cell wall biosynthesis is a widely used target for chemotherapeutic intervention in bacterial infections. In mycobacteria, the cell wall is comprised of mycolic acids, very long chain fatty acids that provide protection and allow the bacteria to persist in the human macrophage. The type II fatty acid biosynthesis pathway in Mycobacterium tuberculosis synthesizes fatty acids with a length of up to 56 carbon atoms that are the precursors of the critical mycobacterial cell wall components mycolic acids. KasA, the mycobacterial ß-ketoacyl synthase and InhA, the mycobacterial enoyl reductase, are essential enzymes in the fatty acid biosynthesis pathway and validated drug targets. In this work, KasA was expressed in Mycobacterium smegmatis, purified and co-crystallized in complex with the natural thiolactone antibiotic thiolactomycin (TLM). High-resolution crystal structures of KasA and the C171Q KasA variant, which mimics the acyl enzyme intermediate of the enzyme, were solved in absence and presence of bound TLM. The crystal structures reveal how the inhibitor is coordinated by the enzyme and thus specifically pinpoint towards possible modifications to increase the affinity of the compound and develop potent new drugs against tuberculosis. Comparisons between the TLM bound crystal structures explain the preferential binding of TLM to the acylated form of KasA. Furthermore, long polyethylene glycol molecules are bound to KasA that mimic a fatty acid substrate of approximately 40 carbon atoms length. These structures thus provide the first insights into the molecular mechanism of substrate recognition and reveal how a wax-like substance can be accommodated in a cytosolic environment. InhA was purified and co-crystallized in complex with the slow, tight binding inhibitor 2-(o-tolyloxy)-5-hexylphenol (PT70). Two crystal structures of the ternary InhA-NAD+-PT70 were solved and reveal how the inhibitor is bound to the substrate binding pocket. Both structures display an ordered substrate binding loop and corroborate the hypothesis that slow onset inhibition is coupled to loop ordering. Upon loop ordering, the active site entrance is more restricted and the inhibitor is kept inside more tightly. These studies provide additional information on the mechanistic imperatives for slow onset inhibition of enoyl ACP reductases.},
  subject      = {Tuberkelbakterium},
  language  = {en}
}
@phdthesis{Lee2013,
  author    = {Lee, Wook},
  title     = {Computational study on the catalytic mechanism of mtKasA},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-83989},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2013},
  abstract  = {Das Enzym KasA spielt eine entscheidende Rolle in der Biosynthese von Mykols{\"a}uren, den Bausteinen der Zellw{\"a}nde von Mycobacteriumtuberculosis. Dessen essentielle Notwendigkeit zeigt sich bei Abwesenheit von KasA in einer Zelllyse (Aufl{\"o}sung von Zellen) bei Mycobacteriumtuberculosis. Durch seine Bedeutung f{\"u}r Mycobacteriumtuberculosis, dem Erreger von Tuberkulose und damit der zweith{\"a}ufigsten Todesursache durch Infektionskrankheiten, stellt KasA ein vielversprechendes Ziel f{\"u}r die Entwicklung neuer Medikamente gegen Tuberkulose dar. Durch das Auftreten von extensiv resistenten St{\"a}mmen welche die meisten bekannten Antibiotika zur Bek{\"a}mpfung von Tuberkulose inaktivieren wird es dringend notwendig neue Medikamente gegen Tuberkulose zu entwickeln. In Kapitel 3.1 wird der Protonierungszustand der katalytischen Reste im Ruhezustand untersucht. F{\"u}r diese Untersuchungen wurden Free Energy Perturbation (FEP) Rechnungen und MD Simulationen verwendet. Die Ergebnisse zeigten, dass der zwitterionische Zustand am wahrscheinlichsten ist. Um diese Aussage mit weiteren handfesten Daten zu untermauern wurden Potential(hyper)fl{\"a}chen (PES) f{\"u}r den Protonentransfer zwischen neutralen und zwitterionischen Zustand mit Hilfe von QM/MM Methoden berechnet. Durch die starke Abh{\"a}ngigkeit der QM/MM Optimierung von der Ausgangsstruktur war es nicht m{\"o}glich konsistente Ergebnisse f{\"u}r diese Berechnungen zu bekommen. Um dieses Problem zu umgehen wurde ein auf QM/MM basierendes Umbrella Sampling mit Semiempirischen Methoden (RM1) durchgef{\"u}hrt. Die sich daraus ergebende PMF Fl{\"a}che zeigt das der zwitterionische Zustand stabiler ist als der neutrale Zustand. In Kapitel 3.2 wurde der Protonierungszustand der entsprechenden Reste im Acyl-Enzym Zustand untersucht. Im Unterschied zu anderen katalytischen Resten ist der Protonierungszustand von His311 ist nicht eindeutig im Acyl-Enzym Zustand und es ergeben sich aus den verschiedenen Protonierungszust{\"a}nden verschiedene Decarboxylierungsmechanismen. Um den wahrscheinlichsten Protonierungszustand bez{\"u}glich der freien Energie zu bestimmen wurden FEP Rechnungen durchgef{\"u}hrt. Die Ergebnisse zeigen, dass der pKa Wert an Nδ betr{\"a}chtlich durch die Enzymumgebung verringert wird, w{\"a}hrend dies f{\"u}r Nε nicht der Fall ist. Zus{\"a}tzlich dazu wurden die PMF Profile f{\"u}r den Protonentransfer zwischen Lys340 und Glu354 mit der QM/MM basierten Umbrella Sampling Methode berechnet. Die Ergebnisse zeigen, dass das Lys340/Glu354 Paar eher neutral als ionisch ist, wenn His311 an Nε protoniert ist. Ein relativ hoher ionischer Charakter des Lys340/Glu354 Paares, wenn His311 doppelt protoniert ist, gibt einen wertvollen Einblick in die Rolle welche das Lys340/Glu354 Paar beim verschieben des Protonierungszustandes von Nδ zu Nε im His311 nach dem Acyltransferschritt spielt. Die Ergebnisse zeigen, dass His311 neutral und an Nε protoniert ist. Ebenso ist das Lys340/Glu354 Paar neutral im Acyl-Enzym Zustand. Diese berechneten Ergebnisse f{\"u}hren zu dem Schluss, dass die Decarboxylierung durch ein Oxyanion Loch erleichtert wird welches aus zwei katalytischen Histidin Resten besteht. In Kapitel 3.3 wurde der Protonierungszustand der katalytischen Reste im Ruhezustand erneut untersucht da eine aktuelle Benchmarkstudie zeigte, dass die verwendete Semiempirische Methode (RM1) in Kapitel 3.1 dazu tendiert die Stabilisation des zwitterionischen Zustandes zu {\"u}bersch{\"a}tzen. Auch wurde in Kapitel 3.1 das Lys340/Glu354 Paar als rein ionisch angesehen, w{\"a}hrend sich in Kapitel 3.2 herausstellte, dass es sich um eine Mischung aus neutralen und ionischen Charakter handelt. Die neuen Untersuchungen beinhalten eine gr{\"o}ßere QM Region inklusive des Lys340/Glu354 Paares. Der daf{\"u}r verwendete BLYP/6-31G** Ansatz ist ausreichend akkurat f{\"u}r die aktuelle Fragestellung, was durch Vergleichsrechnungen bewiesen wurde. Die neuen Ergebnisse der QM/MM MD und FEP Rechnungen deuten an, dass die katalytischen Reste im Ruhezustand h{\"o}chst wahrscheinlich neutral vorliegen. Dies wiederum f{\"u}hrt zu der Frage wie KasA aktiviert werden kann um die katalytische Reaktion zu initiieren. Auf der Basis der Ergebnisse der MD Simulationen und FEP Rechnungen f{\"u}r den His311Ala Mutanten in Kapitel 3.1 stellten wir die Hypothese auf, dass die offene Konformation von Phe404 die Aktivierung der katalytischen Reste durch die (Aus)bildung einer starken Wasserstoffbindung einleitet. Die QM/MM MD Simulation best{\"a}tigt dass diese Aktivierung der katalytischen Reste durch die offene Konformation des Phe404 bewerkstelligt werden kann. Das entsprechende auf Kraftfeld basierende PMF Profil zeigt auch, dass dieser Konformationswechsel energetisch realisierbar ist. Die Verteilung der hydrophilen und hydrophoben Reste in der Malonyl Bindungstasche in Verbindung mit unseren berechneten Ergebnissen geben einen Einblick in den detaillierten},
  subject      = {Tuberkelbakterium},
  language  = {en}
}
@phdthesis{Kesetovic2016,
  author    = {Kesetovic, Diana},
  title     = {Synthesis and biological testing of potential anti-tuberculosis drugs targeting the β-ketoacyl ACP synthase},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-131301},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2016},
  abstract  = {With 9.6 million new cases and 1.5 million deaths in 2014, tuberculosis (TB) is alongside with AIDS the most deadly infection.‎ Foremost, the increased prevalence of resistant strains of M. tuberculosis among the TB-infected population represents a serious thread. Hence, in the last decades, novel drug targets have been investigated worldwide. So far a relatively unexplored target is the cell wall enzyme β-ketoacyl-ACP-synthase "KasA", which plays a crucial role in maintaining the membrane impermeability and hence the cell ability to resist to the immune response and drug therapy. KasA is a key enzyme in the fatty acid synthase "FAS-II" elongation cycle, responsible for the extension of the growing acyl chain within the biosynthesis of precursors for the most hydrophobic constituents of the cell wall - mycolic acids. Design of the novel KasA inhibitors, performed in the research group of Prof. Sotriffer by C. Topf and B. Schaefer, was based on the recently published crystal structure of KasA‎ in complex with its known inhibitor thiolactomycin (TLM). Considering the essential ligand-enzyme interactions, a pharmacophore model was built and applied in the virtual screening of a modified ZINC database. Selected hits with the best in silico affinity data have been reported by Topf‎ and Schaefer‎. In this work, two of the obtained hits were synthesized and their structure was systematically varied. First, a virtual screening hit, chromone-2-carboxamide derivative GS-71, was modified in the amide part. Since the most of the products possessed a very low solubility in the aqueous buffer medium used in biological assays, polar groups (nitro, succinamidyl and trimethyl-amino substituent in position 6 of the chromone ring or hydroxyl group on the benzene ring in the amide part have been inserted to the molecule. Further variations yielded diaryl ketones, diaryl ketone bearing a succinamidyl substituent, carboxamide bearing a methylpiperazinyl-4-oxobutanamido group and methyl-malonyl ester amides. Basically, the essential structural features necessary for the ligand-enzyme interactions have been maintained. The latter virtual screening hit, a pyrimidinone derivative VS-8‎ was synthesized and the structure was modified by substitution in positions 2, 4, 5 and 6 of the pyrimidine ring. Due to autofluorescence, detected in most of the products, this model structure was not further varied. Simultaneously, experiments on solubilization of the first chromone-2-carboxamides with cyclodextrins, cyclic oligosacharides known to form water-soluble inclusion complexes, were performed. Although the assessed solubility of the chromone 3b/DIMEB (1:3) mixture exceeded 14-fold the intrinsic one, the achieved 100 µM solubility was still not sufficient to be used as a stock solution in the binding assay. The experiments with cyclodextrin in combination with DMSO were ineffective. Owing to high material costs necessary for the appropriate cyclodextrin amounts, the aim focused on structural modification of the hydrophobic products. Precise structural data have been obtained from the solved crystal structures of three chromone derivatives: the screening hit GS-71 (3b), its trimethylammonium salt (18) and 6-nitro-substituted N-benzyl-N-methyl-chromone-2-carboxamide (9i). The first two compounds are nearly planar with an anti-/trans-rotamer configuration. In the latter structure, the carboxamide bridge is bent out of the chromone plane, showing an anti-rotamer, too. Considering the relatively low partition coefficient of compound 3b (cLogP = 2.32), the compound planarity and correlating tight molecular packing might be the factors significantly affecting its poor solubility. Regarding the biological results of the chromone-based compounds, similar structure-activity correlations could be drawn from the binding assay and the whole cell activity testing on M. tuberculosis. In both cases, the introduction of a nitro group to position 6 of the chromone ring and the presence of a flexible substituent in the amide part showed a positive effect. In the binding study, the nitro group at position 4 on the N-benzyl residue was of advantage, too. The highest enzyme affinity was observed for N-(4-nitrobenzyl)-chromone-2-carboxamide 4c (KD = 34 µM), 6-nitro substituted N-benzyl-chromone-2-carboxamide 9g (KD = 40 µM) and 6‑nitro-substituted N-(4-nitrobenzyl)-chromone-2-carboxamide 9j (KD = 31 µM), which could not be attributed to the fluorescence quenching potential of the nitro group. The assay interference potential of chromones, due to a covalent binding on the enzyme sulfhydryl groups, was found to be negligible at the assay conditions. Moderate in vivo activity was detected for 6‑nitro-substituted N-benzyl-chromone-2-carboxamide 9g and its N-benzyl-N-methyl-, N‑furylmethyl-, N-cyclohexyl- and N-cyclohexylmethyl derivatives 9i, 9d, 9e, 9f, for which MIC values 20 - 40 µM were assessed. Cytotoxicity was increased in the N‑cyclohexylmethyl derivative only. None of the pyrimidine-based compounds showed activity in vivo. The affinity of the model structure, VS-8, surpassed with KD = 97 µM the assessed affinity of TLM (KD = 142 µM). Since for the model chromone compound GS-71 no reliable KasA binding data could be obtained, a newly synthesized chromone derivative 9i was docked into the KasA binding site, in order to derive correlation between the in silico and in vitro assessed affinity. For the 6‑nitro-derivative 9i a moderate in vivo activity on M. tuberculosis was obtained. The in silico predicted pKi values for TLM and 9i were higher than the corresponding in vitro results, maintaining though a similar tendency, i.e., the both affinity values for compound 9i (pKi predicted = 6.64, pKD experimental = 4.02) surpassed those obtained for TLM (pKi predicted = 5.27, pKD experimental = 3.84). Nevertheless, the experimental pKD values are considered preliminary results. The binding assay method has been improved in order to acquire more accurate data. Owing to the method development, limited enzyme batches and solubility issues, only selected compounds could be evaluated. The best hits, together with the compounds active on the whole cells of M. tuberculosis, will be submitted to the kinetic enzyme assay, in order to confirm the TLM-like binding mechanism. Regarding the in vivo testing results, no correlations could be drawn between the predicted membrane permeability values and the experimental data, as for the most active compounds 9e and 9f, a very low permeability was anticipated (0.4 and 0.7 \%, respectively). Further biological tests would be required to investigate the action- or transport mode.},
  subject      = {Tuberkelbakterium},
  language  = {en}
}
@phdthesis{Diwischek2008,
  author    = {Diwischek, Florian},
  title     = {Development of synthesis pathways and characterization of cerulenin analogues as inhibitors of the fatty acid biosynthesis of Mycobacterium tuberculosis and of efflux pump resistant Candida albicans},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-27532},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2008},
  abstract  = {The work deals with the synthesis and characterization of cerulenin analogues as inhibitors of efflux pump mediated resistance of Candida albicans isolates and as inhibitors of the fatty acid synthesis enzyme KasA of Mycobacterium tuberculosis. Cerulenin was chosen as the lead structure, being a substrate of the efflux pumps in Candida albicans on one hand and therefore variations on the structure could lead to a blocking of the efflux pumps as in the case of tetracycline and inhibitor 13-CPTC of the TetB efflux pump. On the other hand, cerulenin is a known inhibitor of the FAS system but inhibition is unselective in type I and II FAS. Therefore, analogues could result in increased selectivity towards the type II FAS system in M. tuberculosis. The first cerulenin derivatives were prepared by coupling 2,3-dihydrofuran to the before synthesized 1-octaniodide, followed by ring opening and oxidation in one step by chromic acid and transfer of the resulting 4-keto acid to amides to give analogues 4a-d, 4e was prepared in analogy. To include the epoxide function especially with regard to the mechanism of action of cerulenin in the FAS system (considering known crystal structures of cerulenin and the KasA analogue of E. coli) tetrahydro- and dihydrocerulenin analogues were synthesized. Starting from the corresponding aldehyde, lactone 5 (tetrahydrocerulenin analogues) was obtained via two different routes A and B. Route A included the coupling of the aldehyde 1-nonanal to propiolic acid via a Grignard reaction with subsequent hydrogenation with the Lindlar catalyst under hydrogen pressure to give 5. Via Route B 1-nonanal was coupled to methyl propiolate by n-BuLi with subsequent hydrogenation under reflux with the catalytic system Lindlar cat./NH4HCO2 to yield 5. These hydrogenations were also executed in a microwave oven resulting in better yields and/or reaction times. The lactone 5 was then epoxidized, the ring opened by amidation and the remaining alcohol was oxidized via Collins oxidation to result in tetrahydrocerulenin analogues 8a-e. The same procedure was used for dihydrocerulenin analogues 10a-c except that to obtain the corresponding lactone 9a only route A was used and a further step had to be executed for ring closure. To obtain analogues with all structural features of cerulenin including two double bonds and the epoxide function, a third pathway was chosen. To obtain the future side chain, aldehyde 12 was synthesized by coupling protected 4-pentyn-1-ol to either crotyl bromide or crotyl chloride, which then was deprotected, hydrogenated with Lindlar catalyst under hydrogen pressure and oxidized via a Swern oxidation. The following synthesis sequence starting from 12 was executed similar to that of dihydrocerulenins via the corresponding lactone (51) with the major exception of the oxidation procedure in the last step via TPAP/NMO to result in (4Z,7E)-cerulenin analogues 15a-b. A fourth class of cerulenin analogues was synthesized with the aromatic analogues 17a-e. This synthesis pathway started with the formation of the benzoyl acrylamides 16a-e from benzoylacrylic acid via a mixed anhydride which was prepared with isobutylchloroformate followed by the addition of the corresponding amine. Subsequent epoxidation with H2O2 in basic EtOH gave the aromatic cerulenin analogues 17a-e. Pharmacological testings for the synthesized substances were executed on efflux pump-resistant and -sensitive Candida albicans isolates, on the fatty acid synthesis enzyme KasA of Mycobacterium tuberculosis and on other organisms such as Leishmania major, Trypanosoma brucei brucei, Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Pseudomonas aeruginosa within the Sonderforschungsbereich 630.},
  subject      = {Organische Synthese},
  language  = {en}
}